- Home
- KZIA vs GSUN Comparison
KZIA vs GSUN Comparison
Compare KZIA & GSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- GSUN
- Stock Information
- Founded
- KZIA 1994
- GSUN 1997
- Country
- KZIA Australia
- GSUN China
- Employees
- KZIA N/A
- GSUN N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- GSUN Other Consumer Services
- Sector
- KZIA Health Care
- GSUN Real Estate
- Exchange
- KZIA Nasdaq
- GSUN Nasdaq
- Market Cap
- KZIA 6.0M
- GSUN 6.0M
- IPO Year
- KZIA 1999
- GSUN 2022
- Fundamental
- Price
- KZIA $0.88
- GSUN $2.65
- Analyst Decision
- KZIA Strong Buy
- GSUN
- Analyst Count
- KZIA 2
- GSUN 0
- Target Price
- KZIA $11.50
- GSUN N/A
- AVG Volume (30 Days)
- KZIA 5.5M
- GSUN 4.7K
- Earning Date
- KZIA 03-26-2025
- GSUN 03-04-2025
- Dividend Yield
- KZIA N/A
- GSUN N/A
- EPS Growth
- KZIA N/A
- GSUN N/A
- EPS
- KZIA N/A
- GSUN N/A
- Revenue
- KZIA $1,655,324.00
- GSUN $10,159,020.00
- Revenue This Year
- KZIA N/A
- GSUN N/A
- Revenue Next Year
- KZIA N/A
- GSUN N/A
- P/E Ratio
- KZIA N/A
- GSUN N/A
- Revenue Growth
- KZIA 248000.00
- GSUN 65.04
- 52 Week Low
- KZIA $0.85
- GSUN $2.21
- 52 Week High
- KZIA $15.80
- GSUN $9.93
- Technical
- Relative Strength Index (RSI)
- KZIA 29.00
- GSUN 42.02
- Support Level
- KZIA $0.90
- GSUN $2.55
- Resistance Level
- KZIA $1.60
- GSUN $2.77
- Average True Range (ATR)
- KZIA 0.14
- GSUN 0.15
- MACD
- KZIA 0.02
- GSUN -0.02
- Stochastic Oscillator
- KZIA 4.00
- GSUN 15.38
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About GSUN Golden Sun Education Group Limited
Golden Sun Health Technology Group Ltd is engaged in the provision of education and management services in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistic and consulting services. The company operates in two segments; Education segment and the Wellness segment. Majority of the revenue is generated from the Education segment which offers foreign language tutorial services and other education training management services in China. The wellness segment offers wellness service and related products.